Latest
← Signal: Tech & AI

Anthropic Files for IPO on Nasdaq, Disclosing $80.7B Net Loss Despite $16B Revenue Growth

Developing1 source · Oct 26, 2026

The AI safety-focused company plans to go public under ticker ANT, revealing significant losses and extensive risk factors including potential existential threats from its own technology.

Anthropic Files for IPO on Nasdaq, Disclosing $80.7B Net Loss Despite $16B Revenue Growth
Image via Wired

What happened

Anthropic filed its S-1 prospectus on Monday for a Nasdaq IPO expected in late November under the ticker ANT. The filing reveals revenue of more than $16 billion in the first half of 2026, up from about $4.5 billion in 2025, with a high-value customer base including roughly 250 customers spending $10 million or more annually. However, the company posted a net loss of $80.7 billion in the first half of 2026, compared to a net loss of $13 billion in the same period last year. The S-1 prospectus does not include details on planned fundraising amount or valuation; The New York Times reported in August that the company was looking to raise more than $100 billion with a valuation around $2 trillion. The filing details extensive risk factors, including potential catastrophic or existential risks from advanced AI systems, concerns about loss of model control, and the Trump administration's designation of Anthropic as a supply chain risk.

Context

Anthropic's IPO comes as OpenAI announced in September it no longer intends to go public this year, citing concerns about AI risks to humanity. Anthropic, founded in 2021 by seven former OpenAI employees who questioned OpenAI's safety approach, positions itself as a safety-conscious alternative in the AI industry. The company's massive losses despite significant revenue growth reflect the capital-intensive nature of developing and operating large-scale AI models. The inclusion of existential risk warnings in the prospectus underscores a central tension: Anthropic must attract investors while simultaneously warning them that the technology it develops could pose catastrophic or existential threats. Government regulatory uncertainty, particularly the Trump administration's supply chain designation, adds additional financial and operational risk to the company's business model.